Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients

Faouzi Djebbari; Faye A. Sharpley; Susan McLain-Smith; Grant Vallance; Toby A. Eyre; Jaimal Kothari; Sally Moore; Karthik Ramasamy

doi:10.1371/journal.pone.0229469

Loading metrics

Open Access

Peer-reviewed

Research Article

Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients

Faouzi Djebbari ,

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing

* E-mail: faouzi.djebbari@ouh.nhs.uk

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

http://orcid.org/0000-0001-9578-7632

⨯
Faye A. Sharpley,

Roles Data curation, Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Susan McLain-Smith,

Roles Formal analysis

Affiliation PH Associates, Marlow, United Kingdom
⨯
Grant Vallance,

Roles Project administration

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

http://orcid.org/0000-0001-6539-4002

⨯
Toby A. Eyre,

Roles Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Jaimal Kothari,

Roles Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Sally Moore,

Roles Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯
Karthik Ramasamy

Roles Conceptualization, Investigation, Methodology, Resources, Supervision, Validation, Writing – review & editing

Affiliation Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⨯

Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients

Faouzi Djebbari,
Faye A. Sharpley,
Susan McLain-Smith,
Grant Vallance,
Toby A. Eyre,
Jaimal Kothari,
Sally Moore,
Karthik Ramasamy

Published: February 21, 2020
https://doi.org/10.1371/journal.pone.0229469

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Multiple myeloma
Is the Subject Area "Multiple myeloma" applicable to this article?

Thanks for your feedback.
Myeloma
Is the Subject Area "Myeloma" applicable to this article?

Thanks for your feedback.
Toxicity
Is the Subject Area "Toxicity" applicable to this article?

Thanks for your feedback.
Cyclophosphamide
Is the Subject Area "Cyclophosphamide" applicable to this article?

Thanks for your feedback.
Age groups
Is the Subject Area "Age groups" applicable to this article?

Thanks for your feedback.
Stem cell therapy
Is the Subject Area "Stem cell therapy" applicable to this article?

Thanks for your feedback.
Cytogenetics
Is the Subject Area "Cytogenetics" applicable to this article?

Thanks for your feedback.